- Home
- ATOS vs ABAT Comparison
ATOS vs ABAT Comparison
Compare ATOS & ABAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATOS
- ABAT
- Stock Information
- Founded
- ATOS 2009
- ABAT 2011
- Country
- ATOS United States
- ABAT United States
- Employees
- ATOS N/A
- ABAT N/A
- Industry
- ATOS Biotechnology: Pharmaceutical Preparations
- ABAT Metal Mining
- Sector
- ATOS Health Care
- ABAT Basic Materials
- Exchange
- ATOS Nasdaq
- ABAT Nasdaq
- Market Cap
- ATOS 96.8M
- ABAT 87.2M
- IPO Year
- ATOS 2012
- ABAT N/A
- Fundamental
- Price
- ATOS $0.65
- ABAT $1.02
- Analyst Decision
- ATOS Strong Buy
- ABAT
- Analyst Count
- ATOS 3
- ABAT 0
- Target Price
- ATOS $7.00
- ABAT N/A
- AVG Volume (30 Days)
- ATOS 520.3K
- ABAT 944.0K
- Earning Date
- ATOS 03-25-2025
- ABAT 05-14-2025
- Dividend Yield
- ATOS N/A
- ABAT N/A
- EPS Growth
- ATOS N/A
- ABAT N/A
- EPS
- ATOS N/A
- ABAT N/A
- Revenue
- ATOS N/A
- ABAT $877,900.00
- Revenue This Year
- ATOS N/A
- ABAT $31,748.62
- Revenue Next Year
- ATOS N/A
- ABAT N/A
- P/E Ratio
- ATOS N/A
- ABAT N/A
- Revenue Growth
- ATOS N/A
- ABAT N/A
- 52 Week Low
- ATOS $0.65
- ABAT $0.73
- 52 Week High
- ATOS $2.31
- ABAT $4.11
- Technical
- Relative Strength Index (RSI)
- ATOS 31.82
- ABAT 46.10
- Support Level
- ATOS $0.66
- ABAT $0.97
- Resistance Level
- ATOS $0.71
- ABAT $1.22
- Average True Range (ATR)
- ATOS 0.04
- ABAT 0.10
- MACD
- ATOS -0.00
- ABAT 0.02
- Stochastic Oscillator
- ATOS 0.00
- ABAT 37.50
About ATOS Atossa Therapeutics Inc.
Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary innovative medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.
About ABAT American Battery Technology Company
American Battery Technology Co is engaged in lithium-ion battery recycling, battery metals and material extraction, and resource production. It is a battery metals company producing low-cost battery metals with a commitment to closed-loop, clean energy technologies.